Fact CheckerSign in

NCT06497309Completed

Advanced Technology-Based Rehabilitation for Gait Relearning After Stroke

Advanced Technology-based Rehabilitation Programmes to Support Gait Re-learning After Stroke

Source: ClinicalTrials.gov · Last updated 9 Sept 2026

Brief summary (registry, in English)

High-tech therapy, an innovative field of neurorehabilitation, has expanded rapidly in recent years. Advances in technology have enabled the use of devices that can assist with movement development from simple movements to more complex tasks. This research investigates the effectiveness of rehabilitation programmes that complement robot-assisted therapy to help people relearn to walk in post-stroke rehabilitation. This would be measured in two variations, with the patient (in addition to a complex rehabilitation programme of conventional physiotherapy, occupational therapy, hydrotherapy, etc.) receiving either treadmill or no treadmill treatment. In both cases, the therapies will be carried out with advanced technology-based equipment (both treatments are part of the daily routine of the Institute's treatments, and the equipment will be used according to the instructions in the user manual), the C-Mill interactive robot-assisted device will be used for treadmill therapy, and the Andago robot-assisted device for non- treadmill therapy. There is no sharp distinction between the two systems. The inclusion and exclusion criteria are set so patients' conditions meet the indications for both devices, and patients eligible for treatment with one device are included in the other. In our study, 80 patients will be selected.

Status (registry)
Completed
Study type
Interventional
Enrollment
80 (actual)
First submitted
3 Apr 2024
Start date
1 Jan 2024
Primary completion date
11 Feb 2026
Lead sponsor
National Institute for Medical Rehabilitation, Hungary
Diseases
Stroke
NCT number
NCT06497309

What you commit to

  • Study type: Interventional
  • Participants enrolled: 80
  • From 1 Jan 2024 to the primary completion date, 11 Feb 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • patients treated with botulinum toxin in the lower limb in the last 3 months;

Other illness

  • More than 1 year has passed since the stroke;
  • patients who were unable to walk independently before the stroke;
  • severe aphasia (impairment of understanding or expression that severely impedes communication);
  • other condition that precludes the use of C-Mill or Andago:
    • severe emotional disturbance;
    • mentally incapacitated patient;
    • severe contracture or spasticity preventing the patient from being placed in the machine;
    • pregnancy;
    • skin disease in the area of contact with the straps;
    • fever;
    • unhealed fracture fracture;
    • inability to use the device due to weight and height limitations of the device;
    • epilepsy if you have had a seizure within a year;
    • severe visual impairment.

Other

  • scores less than or equal to 3 on the Functional Ambulation Categories (FAC) scale;
  • use of other lower limb advanced technology treatments during the study;
  • a person with limited capacity;
  • not physically able to bear weight;

Who the study is looking for

  • Hemiparetic patient who has had a stroke;
  • ischaemic or haemorrhagic stroke confirmed by CT or MRI;
  • female or male between 40 and 75 years of age;
  • subgroup 1: less than 3 months since stroke,
  • subgroup 2: more than 3 months but less than 1 year since stroke;
  • physical fitness adequate for the exertion of the treatment;
  • right or left lower limb involvement;
  • score 3 on the Functional Ambulation Categories (FAC) scale, i.e. Indicates a patient who can ambulate on a level surface without manual contact of another person but requires standby guarding of one person either for safety or verbal cueing;
  • or score 4 on the Functional Ambulation Categories (FAC) scale, i.e. Indicates a patient who can ambulate independently on a level surface but requires supervision to negotiate (e.g. stairs, inclines, non-flat surfaces);
  • be able to participate in therapy and cooperate based on cognitive function;
  • signed informed consent.

Age in the registry: 30 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
National Institute for Medical Rehabilitation
Coordinator of this site? Confirm its status		BudapestHungaryUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.